These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24337979)

  • 1. Understanding proximal-distal economic projections of the benefits of childhood preventive interventions.
    Slade EP; Becker KD
    Prev Sci; 2014 Dec; 15(6):807-17. PubMed ID: 24337979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discounting in health care decision-making: time for a change?
    Sheldon TA
    J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research priorities for economic analyses of prevention: current issues and future directions.
    Crowley DM; Hill LG; Kuklinski MR; Jones DE
    Prev Sci; 2014 Dec; 15(6):789-98. PubMed ID: 23963624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standards of Evidence for Conducting and Reporting Economic Evaluations in Prevention Science.
    Crowley DM; Dodge KA; Barnett WS; Corso P; Duffy S; Graham P; Greenberg M; Haskins R; Hill L; Jones DE; Karoly LA; Kuklinski MR; Plotnick R
    Prev Sci; 2018 Apr; 19(3):366-390. PubMed ID: 29435786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
    Williams I; McIver S; Moore D; Bryan S
    Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services.
    Carande-Kulis VG; Maciosek MV; Briss PA; Teutsch SM; Zaza S; Truman BI; Messonnier ML; Pappaioanou M; Harris JR; Fielding J
    Am J Prev Med; 2000 Jan; 18(1 Suppl):75-91. PubMed ID: 10806980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation.
    Grant SW; Sperrin M; Carlson E; Chinai N; Ntais D; Hamilton M; Dunn G; Buchan I; Davies L; McCollum CN
    Health Technol Assess; 2015 Apr; 19(32):1-154, v-vi. PubMed ID: 25924187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?
    Husereau D; Culyer AJ; Neumann P; Jacobs P
    Appl Health Econ Health Policy; 2015 Jun; 13(3):273-9. PubMed ID: 25316309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments.
    Ananthapavan J; Moodie M; Milat A; Veerman L; Whittaker E; Carter R
    Health Res Policy Syst; 2021 Dec; 19(1):147. PubMed ID: 34923970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritizing risk factors to identify preventive interventions for economic assessment.
    Wilson N; Blakely T; Foster RH; Hadorn D; Vos T
    Bull World Health Organ; 2012 Feb; 90(2):88-96. PubMed ID: 22423159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cost-effectiveness modeling for better decisions in public research investment of personalized medicine technologies.
    Ling DI; Lynd LD; Harrison M; Anis AH; Bansback N
    J Comp Eff Res; 2019 Jan; 8(1):7-19. PubMed ID: 30525982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of prevention: economic aspects.
    Jönsson B
    Ciba Found Symp; 1985; 110():22-37. PubMed ID: 3921320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies.
    Barbosa C; Dowd WN; Zarkin G
    Value Health; 2020 Aug; 23(8):1096-1108. PubMed ID: 32828223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating information about cost-effectiveness into evidence-based decision-making: the evidence-based practice center (EPC) model.
    Helfand M
    Med Care; 2005 Jul; 43(7 Suppl):33-43. PubMed ID: 16056007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costing bias in economic evaluations.
    Frappier J; Tremblay G; Charny M; Cloutier LM
    J Med Econ; 2015; 18(8):596-9. PubMed ID: 25800456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating option values into the economic evaluation of health care technologies.
    Palmer S; Smith PC
    J Health Econ; 2000 Sep; 19(5):755-66. PubMed ID: 11184803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.